Akroswiss takes a step forward in the interest of patients closing a multi-million CHF funding round
ZUG, Switzerland: May 17, 2021 Akroswiss is developing an innovative and patented Midazolam-based nasal spray to treat patients suffering...
top of page
bottom of page